News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 397–432
- Matches
- 1166
- Sources here
- 20
- Companies here
- 20
Active search
1166 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
EuroDry Ltd. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:EDRY) 2026-08-06
EuroDry Ltd. (EDRY) reported strong Q2 2026 earnings, with revenue up 56.96% year-over-year to $17.7 million and gross profit soaring by 251.8% to $13.6 million. The company's net income reached $6.6 million, and its stock rose 7.93% following the announcement. Insider trading and hedge …
5 Revealing Analyst Questions From Euronet Worldwide’s Q2 Earnings Call
Euronet Worldwide (EEFT) reported mixed Q2 results, missing revenue and non-GAAP earnings expectations due to macroeconomic headwinds in cross-border payments and weaker European ATM activity. Despite this, digital channels showed strong growth, prompting analysts to question management on conservative guidance, strategies for money transfer …
Neurocrine Biosciences (NBIX) CSO Jude Onyia makes bona fide stock gift
Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences (NBIX), made a bona fide gift of 2,409 shares of common stock effective August 4, 2026. This transaction was a charitable contribution, not a market sale, and no value was received for the shares. After this …
Jupiter Neurosciences grants 472,222 director options | JUNS Insider Trading
Jupiter Neurosciences (JUNS) has granted 472,222 stock options to director Andrew Jon Cutler under its 2025 Equity Incentive Plan. This grant, with an exercise price of $0.0900 per share, is in lieu of cash compensation for his board service. The options vest with 25% …
Jupiter Neurosciences executes 1-for-75 reverse stock split By Investing.com
Jupiter Neurosciences, Inc. (NASDAQ:JUNS) announced a 1-for-75 reverse stock split, approved by its board of directors and stockholders. This action is intended to increase the per share trading price to regain compliance with Nasdaq's minimum bid price requirement. The reverse split will reduce outstanding …
Neurocrine Biosciences (NASDAQ:NBIX): A Value Stock With Quality Behind the Discount
Neurocrine Biosciences (NBIX) is presented as a compelling value stock due to its strong valuation score, profitability, and growth prospects despite trading at a higher-than-average P/E. The company boasts excellent financial health, a debt-free balance sheet, and impressive historical and projected EPS and revenue …
CCEP’s 13.0M-share week backs a 17% quarter as beverage peers lag
Coca-Cola Europacific Partners finished the week up 4.1% on its heaviest recent participation, keeping an active weekly Trend Signal intact while the non-alcoholic beverage group remains mixed underneath.
XBP Global Holdings, Inc. (NASDAQ:XBP): Are Analysts Optimistic?
XBP Global Holdings, Inc. (NASDAQ:XBP) is projected to reach profitability by 2028, according to American Diversified Financial analysts, after reporting significant losses. The company, which operates internationally in technology and services, is expected to achieve an aggressive 74% year-on-year growth to meet this target. …
EURONET WORLDWIDE, INC. Q2 2026: Revenue $1108.4M, EPS $1.71— 10-Q Summary
Euronet Worldwide, Inc. reported its Q2 2026 financial results, with revenue increasing to $1108.4 million, a 3% year-over-year growth. However, net income attributable to Euronet decreased by 21% to $77.4 million, and diluted EPS fell by 25% to $1.71 compared to Q2 2025. The …
Euroapi (ENXTPA:EAPI) Stock Sees Fair Value Cut As JPMorgan Rebased Expectations
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Euroapi is back in focus after analysts cut the official price target from €2.90 …
Trading the Move, Not the Narrative: (NGNE) Edition
This article provides an AI-generated analysis for Neoleukin Therapeutics Inc. (NASDAQ: NGNE), highlighting divergent sentiment, choppy conditions, and specific trading strategies. It outlines exceptional risk-reward short setup, position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis. The report suggests signing …
Quantinno Capital Management LP Has $11.12 Million Position in Euronet Worldwide, Inc. $EEFT
Quantinno Capital Management LP increased its stake in Euronet Worldwide, Inc. (NASDAQ:EEFT) by 24.2% in the first quarter, now holding 167,588 shares valued at $11.12 million. Other institutional investors also adjusted their positions, and collectively, institutional investors own 91.6% of the company. Analyst ratings …
Arrowstreet Capital Limited Partnership Sells 207,035 Shares of Euronet Worldwide, Inc. $EEFT
Arrowstreet Capital Limited Partnership reduced its stake in Euronet Worldwide (EEFT) by 86% in the first quarter, selling 207,035 shares and retaining 33,829 shares worth approximately $2.25 million. Despite this, institutional investors collectively own 91.6% of EEFT. Analyst ratings for the stock are mixed …
Euroseas (ESEA) Projected to Release Earnings on Wednesday
Euroseas (ESEA) is projected to release its Q2 2026 earnings before market open on Wednesday, August 12th, with analysts expecting $4.09 per share on $55.98 million in revenue. The company recently reported Q1 earnings of $4.70 per share, exceeding estimates, and increased its quarterly …
Coca-Cola Europacific Partners PLC (CCEP) (Q2 2026) Earnings Call Highlights: Strong H1 Growth ...
This article first appeared on GuruFocus. Revenue: EUR10.7 billion, up 6.1%. Volume Growth: 5.6% overall, or 2.2% on a days-adjusted basis. Revenue per Case: Grew 0.4%. Cost of Sales per Unit Case: Increased by 0.6%. Operating Profit: EUR1.5 billion, up 8.1%, with an operating …
Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup positive 57.1%Coca-Cola Europacific Partners (NASDAQ: CCEP) grows H1 EPS, reaffirms outlook
Coca-Cola Europacific Partners (CCEP) reported strong financial results for the first half of 2026, with revenue up 4.4% and comparable diluted EPS increasing by 10.6% to €2.20. The company reaffirmed its full-year 2026 guidance, targeting revenue growth of 3–4%, operating profit growth of about …
Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup positive 57.1%Coca-Cola Europacific Partners Q2 Earnings Call Highlights
Coca-Cola Europacific Partners (CCEP) reported strong first-half 2026 results with revenue up 6.1% to €10.7 billion and diluted EPS increasing 10.6% to €2.20, driven by broad-based volume growth and market-share gains, particularly in zero-sugar, energy, sports, and hydration categories. The company reaffirmed its full-year …
Coca-Cola Europacific Partners PLC (CCEP) (Q2 2026) Earnings Cal
Coca-Cola Europacific Partners (CCEP) reported strong H1 2026 results with revenue up 6.1% and operating profit up 8.1%, driven by growth in energy and zero-sugar categories and successful FIFA World Cup activations. Despite challenges like modest revenue per case growth and increased cost of …
Seven Fleet Capital Management LP Makes New Investment in Minerva Neurosciences, Inc $NERV
Seven Fleet Capital Management LP has made a new investment in Minerva Neurosciences, acquiring 1.14 million shares valued at approximately $6.9 million, making it their 12th largest position. This new stake represents about 2.44% of Minerva Neurosciences. Institutional interest in Minerva Neurosciences has generally …
EEFT4968461 Bond Redemption Profile
This article provides an overview of the EEFT4968461 bond redemption profile for Euronet Worldwide, Inc.'s 0.75% 15-MAR-2049 bond. It explains that a bond redemption involves the full repayment of principal and accrued interest, detailing where to find redemption type, date, amount, and sinking fund …
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake
An amended Schedule 13G filing reveals that investors led by Bigger Capital Fund, LP have disclosed a beneficial ownership stake of 7.45% in ClearPoint Neuro (CLPT). Michael Bigger, through various affiliations and personal holdings, is deemed to beneficially own 2,272,980 shares of the common …
ProMIS schedules 4:30 p.m. webcast for Aug. 13 update
ProMIS Neurosciences (Nasdaq: PMN) will report its second-quarter 2026 financial results and provide a business update on August 13, 2026. The company will host an investor conference call and webcast on the same day at 4:30 p.m. Eastern Time. U.S. investors can dial 1-877-407-9208, …
EEFT4968461 Bond Profile — Key Metrics
This article provides a bond profile for Euronet Worldwide, Inc.'s 0.75% bond maturing on March 15, 2049, under the symbol EEFT4968461. It details key facts such as the issue date, outstanding amount, face value, and coupon rate, along with a description of Euronet Worldwide's …